Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 222 results for "fda centre for drug evaluation and re..."

Betting on hepatitis C: how financial speculation in drug deve...

Victor Roy , doctoral researcher , Lawrence King , professor of sociology and political economy Department of Sociology, University of Cambridge, Cambridge, UK Correspondence to: V Roy vr260{at} Victor Roy and Lawrence King argue ... British Medical Journal, 1 day ago

10 images for fda centre for drug evaluation and research

Drug Store News, 2 weeks ago
OncLive, 3 months ago
OncLive, 4 months ago
Business Insider, 5 months ago
Yahoo! India, 5 months ago
Himalayan times, 4 months ago
Pharma Letter, 4 months ago
Reuters UK, 5 months ago
Bioresearch Online, 6 months ago
Reliance Trust, 6 months ago

EMA Suspends Drugs Due to Flawed Bioequivalence Studies

The agency recommends suspending drugs developed with bioequivalence studies performed at Semler Research Centre Private Ltd, Bangalore, India. On July 22, 2016, the European Medicines Agency (EMA) recommended the suspension of approved ...
 PharmTech.com1 week ago

US FDA approves ViiV Healthcare's sNDA for dolutegravir to lower weight limit in children & adolescents living with HIV

The US Food and Drug Administration (FDA) has approved ViiV Healthcare's supplemental New Drug Application (sNDA) for dolutegravir 10mg and 25mg oral tablets, reducing the weight limit from at least 40kg to at least 30kg, in ages 6 to less than 12 ...
 PharmaBiz1 month ago ViiV Healthcare Announces FDA Approval to Lower the Weight Limit for dolutegravir in Children and Adolescents Living With HIV  TickerTech.com1 month ago United Kingdom : ViiV Healthcare announces FDA approval to lower the weight limit for dolutegravir in children and adolescents living with HIV [TendersInfo (India)]  Pharmacy Choice1 month ago

FDA approves vaccine to prevent cholera for travellers

13-Jun-2016 North America | Regulatory | Vaccines The US Food and Drug Administration has approved Vaxchora, a vaccine for the prevention of cholera caused by serogroup O1 in adults aged 18 to 64 travelling to cholera-affected areas. Vaxchora ...
 Manufacturing Chemist1 month ago

FDA takes legal action against 4,402 unlawful drug-selling websites

The US Food and Drug Administration (FDA) and the international regulatory and law enforcement agencies have taken action against 4,402 websites that illegally sell dangerous and unapproved prescription drugs to consumers in the country. The FDA ...
 CPhI.cn1 month ago FDA cracks down on illegal internet sales of prescription medicines in Operation Pangea IX  Manufacturing Chemist1 month ago

US researchers call for re-evaluation of microbial testing of Cannabis

Home » tips » / no comments A new US study suggests that some of the medicinal benefits of dispensary grade Cannabis could be compromised because the flowers host potentially harmful yeasts and toxic molds, which cannot be detected by ...
 HealthMediciNet.com1 month ago

Six new drug discovery acceleration projects to be supported by CQDM and OCE

SAN FRANCISCO, CA Partners since 2012, CQDM and the Ontario Centres of Excellence (OCE) are teaming up once again to fund six new game-changing research projects to accelerate drug discovery under the Quebec-Ontario Life Sciences Corridor. A ...
 BiotechnologyFocus.ca1 month ago

Vantage Point - Patient-Reported Data Gain Traction In FDA Decisions

No matter how the US FDA deals with Sarepta Therapeutics' (NASDAQ: SRPT ) Duchenne muscular dystrophy project eteplirsen, one potential solace is that because of fierce activism surrounding the project regulators might now be more attuned than ever ...
 Seeking Alpha1 month ago

ANGLE plc: Use of Parsortix in GANNET53 Drug Trial

2016-07-28 02:08 ET - News Release GUILDFORD, UNITED KINGDOM -- (Marketwired) -- 07/28/16 Angle PLC (AIM: AGL) (OTCQX: ANPCY) For immediate release 28 July 2016 ANGLE plc ("the Company") USE OF PARSORTIX IN GANNET53 DRUG TRIAL IN OVARIAN ...
 Stockwatch2 days ago ANGLE plc (ANPCY: OTCQX International) | ANGLE plc ("the Company"): Initiation of 200 Patient United States Ovarian Cancer Study  OTC Markets3 days ago Angle PLC Use of Parsortix in GANNET53 drug trial  ADVFN UK2 days ago Use of Parsortix in GANNET53 drug trial  MoneyAM2 days ago

ARIA Study Shows Superior Efficacy of Triumeq(R) for Treatment-naive Women Living with HIV

/PRNewswire/ -- ViiV Healthcare today presented 48-week data from the phase IIIb, open-label, international, multi-centre ARIA study which showed superior efficacy for Triumeq® (dolutegravir/abacavir/lamivudine) compared with atazanavir boosted ...
 Biotechgate1 week ago ViiV Healthcare Release: ARIA Study Shows Superior Efficacy Of Triumeq For Treatment-Na??ve Women Living With HIV  BioSpace1 week ago PFIZER : ARIA Study Shows Superior Efficacy of Triumeq® for Treatment-nave Women Living with HIV  4 Traders1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less